The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-centre review of the efficacy of re-challenge with platinum doublet in patients with oesophagogastric cancer treated with first-line trastuzumab and chemotherapy.
 
Jamie Weaver
No Relationships to Disclose
 
Rufqah Ali
No Relationships to Disclose
 
Marie Mckay
No Relationships to Disclose
 
Victoria Foy
No Relationships to Disclose
 
Adeel Khan
No Relationships to Disclose
 
Aimee Cunningham
No Relationships to Disclose
 
Esther McQueenie
No Relationships to Disclose
 
Vikki Owen-Holt
No Relationships to Disclose
 
Kate Williams
No Relationships to Disclose
 
Sara Valpione
Research Funding - Amgen
 
Richard Hubner
Consulting or Advisory Role - Ipsen; Novartis
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Roche
 
Tom Waddell
Stock and Other Ownership Interests - The Christie Clinic LLP
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai Europe; Ipsen; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen
 
Alia Alchawaf
No Relationships to Disclose
 
Wasat Mansoor
Honoraria - BMS; BMS; Servier
Consulting or Advisory Role - BMS; SERVIER
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Ipsen; SERVIER; SERVIER